Harrow Health, Inc. Forecast, price target & analysts
Harrow Health, Inc. Target price 2025 - Analyst rating & recommendation
Harrow Health, Inc. Classifications & Recommendation:
Harrow Health, Inc. Price Target
| Target Price | $58.14 |
| Price | $30.88 |
| Potential |
88.28%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Harrow Health, Inc. 2026 .
The average Harrow Health, Inc. target price is $58.14.
This is
88.28%
register free of charge
$68.25
121.02%
register free of charge
$42.42
37.37%
register free of charge
|
|
| A rating was issued by 11 analysts: 10 Analysts recommend Harrow Health, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Harrow Health, Inc. stock has an average upside potential 2026 of
88.28%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 199.61 | 289.29 |
| 53.32% | 44.93% | |
| EBITDA Margin | 11.83% | 29.55% |
| 17.10% | 149.83% | |
| Net Margin | -8.76% | 4.65% |
| 53.29% | 153.10% |
9 Analysts have issued a sales forecast Harrow Health, Inc. 2025 . The average Harrow Health, Inc. sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Harrow Health, Inc. EBITDA forecast 2025. The average Harrow Health, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 Harrow Health, Inc. Analysts have issued a net profit forecast 2025. The average Harrow Health, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.49 | 0.38 |
| 34.67% | 177.55% | |
| P/E | 81.78 | |
| EV/Sales | 4.45 |
8 Analysts have issued a Harrow Health, Inc. forecast for earnings per share. The average Harrow Health, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Harrow Health, Inc....
Current Harrow Health, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| William Blair |
Locked
➜
Locked
|
Locked | Jun 10 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 12 2025 |
| B. Riley Securities |
Locked
➜
Locked
|
Locked | Apr 01 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 18 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 06 2025 |
| Craig-Hallum |
Locked
➜
Locked
|
Locked | Oct 04 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
William Blair:
Locked
➜
Locked
|
Jun 10 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 12 2025 |
|
Locked
B. Riley Securities:
Locked
➜
Locked
|
Apr 01 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 31 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 18 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 06 2025 |
|
Locked
Craig-Hallum:
Locked
➜
Locked
|
Oct 04 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
